PortfoliosLab logoPortfoliosLab logo
MAZE vs. RVMD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

MAZE vs. RVMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Maze Therapeutics, Inc (MAZE) and Revolution Medicines, Inc. (RVMD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MAZE vs. RVMD - Yearly Performance Comparison


2026 (YTD)2025
MAZE
Maze Therapeutics, Inc
-27.95%159.75%
RVMD
Revolution Medicines, Inc.
22.10%85.45%

Fundamentals

EPS

MAZE:

-$2.97

RVMD:

-$5.09

Total Revenue (TTM)

MAZE:

$0.00

RVMD:

$0.00

Gross Profit (TTM)

MAZE:

-$649.00K

RVMD:

$0.00

EBITDA (TTM)

MAZE:

-$135.32M

RVMD:

-$1.00B

Returns By Period

In the year-to-date period, MAZE achieves a -27.95% return, which is significantly lower than RVMD's 22.10% return.


MAZE

1D
2.90%
1M
-34.53%
YTD
-27.95%
6M
15.12%
1Y
171.12%
3Y*
5Y*
10Y*

RVMD

1D
4.90%
1M
-4.68%
YTD
22.10%
6M
108.24%
1Y
175.03%
3Y*
64.97%
5Y*
15.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Maze Therapeutics, Inc

Revolution Medicines, Inc.

Return for Risk

MAZE vs. RVMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MAZE
MAZE Risk / Return Rank: 8888
Overall Rank
MAZE Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
MAZE Sortino Ratio Rank: 8585
Sortino Ratio Rank
MAZE Omega Ratio Rank: 8787
Omega Ratio Rank
MAZE Calmar Ratio Rank: 8989
Calmar Ratio Rank
MAZE Martin Ratio Rank: 9292
Martin Ratio Rank

RVMD
RVMD Risk / Return Rank: 9696
Overall Rank
RVMD Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9797
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9696
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9696
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MAZE vs. RVMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Maze Therapeutics, Inc (MAZE) and Revolution Medicines, Inc. (RVMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MAZERVMDDifference

Sharpe ratio

Return per unit of total volatility

1.67

3.21

-1.54

Sortino ratio

Return per unit of downside risk

2.45

4.05

-1.60

Omega ratio

Gain probability vs. loss probability

1.36

1.57

-0.21

Calmar ratio

Return relative to maximum drawdown

3.67

6.43

-2.76

Martin ratio

Return relative to average drawdown

12.70

15.24

-2.54

MAZE vs. RVMD - Sharpe Ratio Comparison

The current MAZE Sharpe Ratio is 1.67, which is lower than the RVMD Sharpe Ratio of 3.21. The chart below compares the historical Sharpe Ratios of MAZE and RVMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MAZERVMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.67

3.21

-1.54

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.26

Sharpe Ratio (All Time)

Calculated using the full available price history

0.72

0.34

+0.37

Correlation

The correlation between MAZE and RVMD is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MAZE vs. RVMD - Dividend Comparison

Neither MAZE nor RVMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MAZE vs. RVMD - Drawdown Comparison

The maximum MAZE drawdown since its inception was -52.54%, smaller than the maximum RVMD drawdown of -73.29%. Use the drawdown chart below to compare losses from any high point for MAZE and RVMD.


Loading graphics...

Drawdown Indicators


MAZERVMDDifference

Max Drawdown

Largest peak-to-trough decline

-52.54%

-73.29%

+20.75%

Max Drawdown (1Y)

Largest decline over 1 year

-44.03%

-24.95%

-19.08%

Max Drawdown (5Y)

Largest decline over 5 years

-69.35%

Current Drawdown

Current decline from peak

-42.41%

-21.11%

-21.30%

Average Drawdown

Average peak-to-trough decline

-15.77%

-36.66%

+20.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.71%

10.52%

+2.19%

Volatility

MAZE vs. RVMD - Volatility Comparison

Maze Therapeutics, Inc (MAZE) has a higher volatility of 47.05% compared to Revolution Medicines, Inc. (RVMD) at 9.83%. This indicates that MAZE's price experiences larger fluctuations and is considered to be riskier than RVMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MAZERVMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

47.05%

9.83%

+37.22%

Volatility (6M)

Calculated over the trailing 6-month period

58.66%

39.79%

+18.87%

Volatility (1Y)

Calculated over the trailing 1-year period

102.99%

55.11%

+47.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.77%

60.46%

+40.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

100.77%

64.05%

+36.72%

Financials

MAZE vs. RVMD - Financials Comparison

This section allows you to compare key financial metrics between Maze Therapeutics, Inc and Revolution Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(MAZE) Total Revenue
(RVMD) Total Revenue
Values in USD except per share items